Objective: We sought to compare the outcomes of minimally invasive mitral valve (MV) surgery for anterior (anterior mitral leaflet, AML), posterior (posterior mitral leaflet, PML) or bileaflet (BL) MV prolapse. Methods: Between August 1999 and December 2007, 1230 patients who presented with isolated AML (n = 156, 12.7%), isolated PML (n = 672, 54.6%) or BL (n = 402, 32.7%) MV prolapse underwent minimally invasive MV surgery. The preoperative mitral regurgitation (MR) grade was 3.3 AE 0.8, left ventricular ejection fraction (LVEF) was 62 AE 12% and mean age was 58.9 AE 13.0 years; 836 patients (68.0%) were male. Mean follow-up time was 2.7 AE 2.1 years, and the follow-up was 100% complete. Results: Overall, the MV repair rate was 94.0% (1156 patients). Seventy-four patients (6.0%) received MV replacement. MV repair for PML prolapse was accomplished in 651 patients (96.9%), for AML in 142 patients (91%) and for BL in 363 patients (90.3%). Repair techniques consisted predominantly of leaflet resection and/or implantation of neochordae, combined with ring annuloplasty. Concomitant procedures were tricuspid valve surgery (n = 56), atrial fibrillation ablation (n = 286) and closure of an atrial septal defect or patent foramen ovale (PFO) (n = 89). The overall duration of cardiopulmonary bypass was 127 AE 40 min and aortic cross-clamp time was 78 AE 33 min. The mean postoperative hospital stay was 11.6 AE 9.7 days for the overall group. Early echocardiographic follow-up revealed excellent valve function in the vast majority of patients, regardless of the repair technique, with a mean MR grade of 0.3 AE 0.5. For the overall group, 5-year survival rate was 87.3% (95% CI: 83.9-90.1) and 5-year freedom from cardiac reoperation rate was 95.6% (95% CI: 94.1-96.7). The log-rank test revealed no significant difference between the three groups regarding long-term survival or freedom from reoperation. Conclusions: Minimally invasive MV repair can be achieved with excellent results. Long-term outcomes and reoperation rates for AML prolapse are not significantly different from PML or BL prolapse. #
Introduction
The predominant lesion for degenerative mitral valve (MV) disease is the prolapse of the posterior mitral leaflet (PML), which can be reproducibly repaired in the majority of patients using either quadrangular/triangular leaflet resection or chordae replacement [1, 2] . In contrast, anterior mitral leaflet (AML) prolapse repair is more technically challenging and involves a larger variety of repair techniques such as chordae replacement, chordae transposition, chordae shortening or papillary muscle repositioning. Bileaflet (BL) prolapse is considered the most technically challenging pathology to repair. Relatively few studies have thus far investigated the outcomes of minimally invasive MV surgery based on the underlying MV pathology and type of prolapse [3] [4] [5] [6] . We therefore sought to compare the outcomes of minimally invasive MV surgery for isolated AML, isolated PML and BL prolapse with a particular focus on operative strategies and long-term outcomes for these three groups of patients.
Material and methods

Patients
Amongst the patients who received minimally invasive MV surgery at our institution between August 1999 and December 2007, a total of 1708 patients underwent minimally invasive MV repair. Amongst those patients, 1230 patients (72%) were diagnosed with mitral regurgitation (MR) owing to either predominant prolapse of the AML (156), prolapse of the PML (672) or BL prolapse (402). This cohort of patients forms the focus of the current study and is reported herein. Minimal invasive MV repair patients who were operated on during the same time period but were excluded from the current study included those with isolated annular dilation (n = 436), ischaemic MR (n = 84), endocarditis without mitral prolapse (n = 10) and mixed mitral stenosis and regurgitation (n = 24). Fig. 1 demonstrates the number of minimal invasive MV repair procedures that have been performed at our institution over the years of the current study. Mean preoperative MR grade in the overall group was 3.3 AE 0.8, wherein 0 = no MR, 1+ = trivial or mild MR, 2+ = moderate MR, 3+ = moderate-to-severe MR and 4+ = severe MR. All surviving patients underwent transthoracic echocardiography prior to discharge.
The mean preoperative left ventricular ejection fraction (LVEF) was 62 AE 12% for the entire cohort. The mean age of patients in the overall group was 58.9 AE 13.0 years, and 836 of them (68.0%) were male. Thirty-six patients (2.9%) had previously undergone cardiac surgery: coronary artery bypass grafting (CABG) in 20 patients, valve surgery in 14 patients, CABG and valve procedures in three and congenital surgery in two patients. Details on baseline characteristics and MV pathology are depicted in Tables 1 and 2 .
Surgical technique
All patients underwent minimally invasive MV surgery using a right-lateral mini-thoracotomy and femoral cannulation for cardiopulmonary bypass (CPB) with mild-to-moderate hypothermia. In the vast majority of patients, a transthoracic aortic clamp introduced by Chitwood was used [7] . Details on the minimally invasive operative approach are described elsewhere [8, 9] . In this study, a variety of different MV repair techniques were applied including leaflet resection and implantation of Gore-Tex neochordae (most commonly) and chordal transfer, commissural plication and Alfieri edgeto-edge repair in a minority of patients (see Table 3 ). The decision regarding which technique to use was solely taken according to the preference of the operating surgeon. An annuloplasty ring was implanted in the vast majority of cases, with a complete rigid ring being the most commonly implanted type (Table 3 ). The size of the implanted ring was determined by assessing the intertrigonal distance and the size of the anterior MV leaflet with a standard sizer. Patients in whom the above two methods resulted in a discrepancy, the size of the anterior leaflet was considered the most important measurement. Ablation for atrial fibrillation was performed using either cryo-or radio frequency techniques as described elsewhere. Concomitant atrial fibrillation ablation was performed with a flexible argon-based cryoablation probe, as described previously [10] .
Follow-up
Follow-up information on all patients was collected either through outpatient visit; telephone contact with the patients or the referring physician, respectively; or by a questionnaire. Follow-up was 100% complete with a mean length of 2.7 AE 2.1 years.
Statistical analysis
Categorical variables are expressed as proportions and continuous variables as mean AE standard deviations throughout this study. The baseline characteristics and outcomes were compared using the chi-square analysis (Pearson) for categorical data and the analysis of variance (ANOVA) for continuous variables. Survival and freedom from reoperation were analysed with Kaplan-Meier actuarial methods and compared using the log-rank test. Statistical significance was considered at the p < 0.05 level. All analyses were performed using the SAS JMP7.0 (SAS Institute, Cary, NC, USA). The guidelines for reporting morbidity and mortality after cardiac valvular operations followed [11] . Table 1 displays the preoperative characteristics for the three groups of leaflet pathology patients. BL patients were significantly younger, had more preoperative MR and had a slightly better LVEF than the other patients. AML patients were more likely to be female and to have undergone previous cardiac surgery, and had a slightly higher European system for cardiac operative risk evaluation (EuroSCORE)-predicted risk of mortality.
Results
Detailed information on MV pathology is displayed in Table 2 . Chordae elongation was more frequently observed in BL patients, but chordal rupture was more likely in PML patients. Calcification of the posterior leaflet was more likely to be observed in BL patients, whereas that of the anterior leaflet was more likely in AML patients. Additional leaflet restriction (in addition to the primary leaflet prolapse) and endocarditis were also more frequently found in AML patients.
The overall MV repair rate in this study was 94% (1156 out of 1230 patients), with MV replacement being performed in 6% of patients (n = 74). A significantly different MV repair rate of 90.3% (363 out of 402) for BL prolapse, 91% (142 out of 156) for isolated AML prolapse and 96.9% for isolated PML prolapse (651 out of 672; p < 0.05) was observed. Table 3 displays other intraoperative data for the three groups of patients. Operation times, duration of CPB and aortic cross-clamp times were significantly longer in the BL group compared to the PML and AML groups. As expected, leaflet-specific procedures were more commonly performed in the corresponding leaflet pathology subgroups (see Table 3 ). In addition, chordal transfer, plication of the anterolateral commissure and an edge-to-edge (Alfieri) repair were less frequently performed in the PML group. Concomitant tricuspid valve repair and atrial fibrillation ablation were performed more frequently in the AML group. The intraoperative course was uneventful in all but seven patients (0.6%) who required conversion to sternotomy owing to aortic dissection (one patient), atrio-ventricular disruption (one patient), bleeding from the atrial appendage (two patients), bleeding from the left ventricular apex (two patients) and extensive adhesions to the chest wall (one patient). The conversion to sternotomy rates was not significantly different between groups and the duration of hospital stay was similar in all three groups.
The mean postoperative MR prior to discharge was 0.3 AE 0.5 for the overall group (Table 4) and was not different between groups. Early postoperative LVEF was also not different between groups.
Other early postoperative outcomes are displayed in Table 4 . The 30-day mortality was 1.8% for the overall group (n = 23), and was not different for the three leaflet pathology subgroups. Stroke occurred in 2.4% of all patients (n = 30) and this was not different between groups. We also failed to demonstrate any significant differences between groups with regard to low cardiac output syndrome, reoperation for bleeding or the length of hospital stay.
The Kaplan-Meier estimate for cumulative survival at 5 years for the overall group was 87.3% (95% CI: 83.9-90.1). The 5-year survival was 86.9% (95% CI: 82.0-90.5) for patients with isolated PML prolapse, 80.9% (95% CI: 67.4-89.7) for patients with isolated AML prolapse and 90.7% (95% CI: 84.9-94.4; Fig. 2 ) for patients with BL prolapse. The logrank test detected no significant difference between the groups regarding survival ( p = 0.4).
During the 8-year study period, a total of 51 patients (4.1%) had to undergo cardiac reoperation (Fig. 3) . Reasons for reoperation were CABG in two patients, MV re-repair in 15, MV replacement in 26, aortic valve surgery in six and cardiac transplantation in two patients. Freedom from reoperation at 5 years for the overall group was 95.6% (95% CI: 94.1-96.7). With regard to the different patient groups, 5-year freedom from reoperation rate was 96.1% (95% CI: 94.3-97.4) for patients with isolated PML prolapse, 92.4% (95% CI: 84-96.6) for patients with isolated AML prolapse and 95.9% (95% CI: 93.2-97.5) for patients with BL prolapse. We failed to detect a significant difference between groups regarding freedom from reoperation ( p = 0.5).
Discussion
The current study shows that a very high rate of MV repair can be achieved in patients with mitral prolapse, with excellent survival and freedom from reoperation rates. MV repair was achieved in 94% of patients, even though many patients had complex MV pathology (Table 2 ). Reoperation was required in only 51 of 1230 patients during an 8-year follow-up period, of which 10 required cardiac surgery for non-MV related reasons. Although the mean duration of follow-up was only 2.7 years -as a result of the increasing number of patients that are being referred to our centre for this procedure over the last few years (see Fig. 1 ) -the number of patients that is available for follow-up 5 years postoperatively (n = 238) is enough to draw meaningful conclusions about the efficacy of this procedure.
As previous studies have shown, patients with isolated PML prolapse had the best results in the current study with a MV repair rate of almost 97% and a 5-year freedom from reoperation rate of over 95%. Although the MV repair rate was significantly higher for isolated PML prolapse than for AML or BL prolapse, we failed to detect a significant difference in reoperation rates during follow-up between patient groups.
It is noteworthy that patients with AML prolapse had a higher preoperative EuroSCORE, a higher rate of previous cardiac operations and the highest proportion of concomitant tricuspid valve surgery. Furthermore, there was a nonsignificant trend towards worse postoperative outcomes in the AML group with a freedom from reoperation rate of 92.4% and a 5-year survival rate of 80.9%. These findings compare favourably with previously reported data by other groups [3] [4] [5] [6] .
Braunberger et al. reported a significantly lower longterm freedom from valve-related reoperation rate for patients with AML prolapse when compared to other types of mitral prolapse [5] . This group exclusively applied the classical Carpentier-type MV repair techniques including leaflet resection and sliding annuloplasty [1] . A study published by Mohty et al. showed a higher reoperation rate of 28 AE 7% for AML prolapse, compared to 11 AE 3% for PML prolapse [6] . These findings were further supported by those of David et al., who reported a 12-year freedom from moderate or severe MR of 65 AE 8% for isolated AML, 67 AE 6% for BL prolapse and 80 AE 4% for isolated PML prolapse [3] . Freedom from reoperation rates were also less in the AML group (88 AE 4% vs 94 AE 2% and 96 AE 2% for BL and PML prolapse, respectively), with AML prolapse being the only independent predictor of reoperation. This group performed the implantation of polytetrafluoroethylene (PTFE) neochordae for anterior and BL prolapse. Although each of these studies showed significantly poorer outcomes for patients with AML prolapse, De Bonis et al. reported a similar longterm outcome of up to 14 years for patients with AML and PML repair [4] . This group used the edge-to-edge repair technique for patients with AML prolapse, and quadrangular resection for PML prolapse.
In the present study, many different MV repair techniques were utilised. Carpentier-type leaflet resection and the implantation of neochordae using premeasured loops (the socalled 'loop technique') were used in the vast majority of patients (see Table 3 ), but the frequency of premeasured loop implantation has steadily increased over time at our institution [12, 13] . For AML repair, loops were used in 56.4% of patients, whereas resection was used in only 9%. For PML repair, the numbers were nearly equal with 46.3% receiving loops and 46% undergoing leaflet resection. Since the decision on the repair strategy was at the discretion of the operating surgeon, this distribution of repair techniques underlines the value of the loop technique for the repair of AML prolapse.
Despite the fact that patients with BL prolapse underwent more complex repairs, with significantly longer operation, CPB and aortic cross-clamp times, very acceptable 5-year freedom from reoperation (95.6%) and 5-year survival (87.3%) rates were demonstrated in this group. We believe this finding underscores the philosophy that patients with complex mitral prolapse should also undergo MV repair, although referral of such patients to surgeons and centres with higher MV surgery volumes may be more appropriate [14] .
Interestingly, although details on MV pathology were collected intraoperatively in a prospective manner, five patients of the AML group required additional PML repair and one patient in the PML group required additional AML repair. In addition, premeasured Gore-Tex loops were occasionally required for the opposite leaflet in patients with predominant AML and PML prolapse (Table 3 ). We assume that these 'crossovers' were caused by the morphological changes of the valvular structures induced by the already-finished steps of repair. It is conceivable that this leads to a significant alteration of the valve structure and function with need for subsequent additional correction.
Concomitant repair strategies like chordal transfer were frequently necessary in the AML (17.9% of patients) and BL (19.9%) groups, but were infrequently required in the PML group (2.1%). Our increasing use of premeasured loop implantation over time, however, has resulted in a concomitant steady decrease in the number of patients undergoing chordal transfer. The edge-to-edge Alfieri repair technique with concomitant insertion of an annuloplasty ring was required for more BL prolapse patients (9.2%) than the other two groups (4.5% and 0.9% for AML and PML prolapse, respectively). Despite the fact that the Alfieri procedure was usually performed as a 'bail-out' manoeuvre in patients with residual prolapse or regurgitation after the initial repair attempt, freedom from reoperation rates remained very good in the BL group. We can therefore conclude that the edge-to-edge repair is a worthy and, sometimes, valuable technique for cardiac surgeons to have available when performing more complex MV repairs.
All repair techniques used in the current study were found to be durable with an overall low rate of reoperation of 95.6% at 5 years. Over the complete 8-year study period, the results for AML prolapse were equal to those for BL and isolated PML prolapse. When compared to previous studies [3, 5, 6] , however, our results for AML prolapse were better than those reported by other centres. We firmly believe that our excellent freedom from reoperation rate for AML prolapse is owing to the extensive use of neochordae construction with premeasured loops in such patients [12, 13] . Further studies will be required to determine if our results for the 'loop technique' continue to be durable in the very long term.
Study limitations
The current study is retrospective in nature and is therefore subject to the inherent weaknesses of a retrospective analysis. Another limitation is the lack of long-term echocardiographic follow-up data that are currently avail-able for our patient population. We therefore used reoperation as the primary indicator for MV repair durability. Although freedom from reoperation is a relatively 'hard' outcome, it may underestimate the actual rate of MV repair failure if patients are turned down for subsequent re-do surgery. It is our firm belief that this is a very infrequent event, however, particularly when considering the young age of our patient cohort (mean 58.9 years). Further studies will focus on the long-term echocardiographic outcomes of our patient population.
Conclusion
Minimally invasive MV surgery for mitral prolapse can be performed with very good perioperative and long-term results. Survival and freedom from reoperation rates for patients with isolated AML prolapse are equal to those with PML or BL prolapse in our patient cohort. The extensive use of neochordae (loop technique) for repair of AML prolapse may have been responsible for the excellent outcomes observed in this patient group. Mohr is teaching me. Thus, from my experience I can tell you in order to accomplish a successful repair we mostly use implantation of neochordae in the majority of cases, which has been our approach for the last several years. Although this has changed in a way that in earlier times we used mostly resection, we currently use more and more a loop or the implantation of neochordae for successful repair.
Dr Chitwood: So you are using the respect not resect modus with the chords? Dr Seeburger: Yes. Dr Chitwood: In our bileaflet repair failures, several patients had systolic anterior motion as the reason for reoperation. In these patients we had done sliding plasties. What simple methods can you use to prevent those? I noticed you had no reoperations for systolic anterior motion. What simple methods can be used to prevent failures in patients with long anterior leaflets and a tall posterior leaflet?
Dr Seeburger: Well, to prevent SAM in patients with a tall posterior leaflet we use 10 mm neochords just to cut the leaflet down and to reduce the height of the leaflet. That is what our approach is in most of the cases. Let's say if you have a large anterior leaflet, we usually use a 36 or a 38 ring to prevent SAM.
Dr Chitwood: So you meticulously size the valve and don't downsize the ring, is that correct?
Dr Seeburger: Yes. Dr Chitwood: And you use chords to get greater coaptation? Dr Seeburger: Yes.
